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Introduction: The Integrated Medical Model (IMM) Project represents one aspect of NASA’s 
Human Research Program (HRP) to quantitatively assess medical risks to astronauts for existing 
operational missions as well as missions associated with future exploration and commercial 
space flight ventures. The IMM takes a probabilistic approach to assessing the likelihood and 
specific outcomes of one hundred medical conditions within the envelope of accepted space 
flight standards of care over a selectable range of mission capabilities. A specially developed 
Integrated Medical Evidence Database (iMED) maintains evidence-based, organizational 
knowledge across a variety of data sources. Since becoming operational in 2011, version 3.0 of 
the IMM, the supporting iMED, and the expertise of the IMM project team have contributed to a 
wide range of decision and informational processes for the space medical and human research 
community. This presentation provides an overview of the IMM conceptual architecture and 
range of application through examples of actual space flight community questions posed to the 
IMM project.         
Methods: Figure 1 illustrates the IMM 
modeling system and scenario process. 
As illustrated, the IMM computational 
architecture is based on Probabilistic 
Risk Assessment techniques. 
Nineteen assumptions and limitations 
define the IMM application domain. 
Scenario definitions include crew 
medical attributes and mission 
specific details.  The IMM forecasts 
probabilities of loss of crew life 
(LOCL), evacuation (EVAC), quality 
time lost during the mission, number 
of medical resources utilized and the 
number and type of medical events by 
combining scenario information with in-flight, analog, and terrestrial medical information stored 
in the iMED. In addition, the metrics provide the integrated information necessary to estimate 
optimized in-flight medical kit contents under constraints of mass and volume or acceptable level 
of mission risk. 
Results and Conclusions: Historically, IMM simulations support Science and Technology 
planning, Exploration mission planning, and ISS program operations by supplying simulation 
support, iMED data information, and subject matter expertise to Crew Health and Safety and the 
HRP. Upcoming release of IMM version 4.0 seeks to provide enhanced functionality to increase 
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the quality of risk decisions made using the IMM through a more accurate representation of the 
real world system.   
